Sequential emergence of MRP- and MDA1-gene over-expression as well as MDR1-gene translocation in homoharringtonine-selected K562 human leukemia cell lines

International Journal of Cancer

Volumn 65, Issue 3, 1996, Pages 365-371

  Zhou, Da Cheng ^a   Ramond, Sylvie ^b   Viguie, Franck ^b   Faussat, Anne Marie ^a   Zittoun, Robert ^a   Marie, Jean Pierre ^a,c  

^a BICHAT HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DAUNORUBICIN; ETOPOSIDE; HOMOHARRINGTONINE; MELPHALAN; MITOXANTRONE; VINCRISTINE;

ARTICLE; CELL STRAIN K 562; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; LEUKEMIA; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ATP-BINDING CASSETTE TRANSPORTERS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 7; DRUG RESISTANCE; HARRINGTONINES; HUMANS; LEUKEMIA; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0030069314     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960126)65:3<365::AID-IJC15>3.0.CO;2-9     Document Type: Article

References (22)

1. BROCK, I., HIPFNER, D.R., NIELSEN, B.S., JENSEN, P B., DLELEY, R.G., COLE, S.P.C. and SEHESTED, M., VP-16 (etoposide)-selected H69 small-cell-lung-cancer cells. Cancer Res., 55, 459-462 (1995).
2. CHOMCZYNSKJ, P. and SACCHI, N., Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 62, 156-159 (1987).
3. CHOL, T.-C., SCHMID, F.A., FEINBERG, A., PHILIPS, F.S and HAN, J., Uptake, initial effects, and chemotherapeutic efficacy of harringtonine in murine leukemic cells sensitive and resistant to vincristine and other chemotherapeutic agents. Cancer Res., 43, 3074-3079 (1983).
4. COLE, S.P.C., Pattern of cross-resistance in a multidrug-resistant small-cell-lung-carcinoma cell line. Cancer Chemother. Pharmacol., 26, 250-256 (1990).
5. COLE, S.P.C., BHARDWAJ, G., GERLACH, J.H., MACKIE, J.E., GRANT, C.E., ALMQUIST, K.C., STEWART, A.J., KURZ, E.U., DUNCAN, A.M.V. and DEELEY, R.G., Over-expression of a transporter gene in a multidrug-resistant human lung-cancer cell line. Science, 258, 1650-1654 (1992).
6. DUTRILLAUX, B. and VIEGAS-PEQUIGNOTE, E., High resolution R- and G-banding on the same preparation. Hum. Genet., 57, 93-95 (1981)
7. FELDMAN, E., ARLIN, Z., AHMED, T., MITTELMAN, A., PUCCIO, C., CHUN, H., COOK, P. and BASKIND, P., Homoharringtonine in combination with cytarabine for patients with acute myelogenous leukemia. Leukemia, 6, 1189-1191 (1992).
8. GREM, J.L., CHESON, B.D., KING, S.A., LEYLAND-JONES, B. and SUFFNESS, M., Cephalotaxine esters: anti-leukemic advance or therapeutic failure? J. nat. Cancer Inst. 80, 1095-1103 (1988).
9. HUANG, M.-T., Harringtonine: an inhibitor of initiation of protein synthesis. Mol. Pharmacol., 11, 511-519 (1975).
10. MARSH, W., SICHERI, D. and CENTER, M.S., Isolation and characterization of adriamycin-resistant HL60 cells which are not defective in the initial intracellular accumulation of drug. Cancer Res., 46, 4053-4057 (1986).
11. 1) chronic myelogenous leukemia (CML). Proc. Amer. Soc. Hematol., 78, 170b (1991).
12. PLUMB, J.A., MILROY, R. and KAYE, S.B., Effects of the pH dependence of 3-(4,5-dimetnylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromideformazan absorption on chemosensitivity determined by a novel tetrazolium-based assay. Cancer Res., 49, 4435-4440 (1989).
13. POWELL, R.G., WEISLEDER, D. and SMITH. C.R., Anti-tumor alkaloids from Cephalotaxus harringtonia: structure and activity. J pharm. Sci., 61, 1227-1230 (1972).
14. RUSSO, D., MICHELUTTI, A., MELLI, C., DAMIAMI, D., MICHIELI, M.-G., CANDONI, A., ZHOU, D.-C., MARIE, J.-P., ZITTOUN, R. and BACCARANI, M., MDR-related P170-glycoprotein modulates the cytotoxic activity of homoharringtonine. Leukemia, 9, 513-516 (1995).
15. SAMBROOK, J., FRITSCH, E.F. and MANIATIS, T., Isolation of highmolecular-weight DNA from mammalian cells. In: C. Nolan (ed.), Molecular cloning, a laboratory manual, pp. 9.14-9.23, Cold Spring Harbor Laboratory, New York (1989).
16. SLAPAK, C.A., MIZUNUMA, N. and KUFE, D.W., Expression of the multidrug-resistance-associated protein and P-glycoprotein in doxorubicin-selected human myeloid leukemia cells. Blood. 84, 3113-3121 (1994).
17. SLICHENMYER, W.J. and VON HOFF, D.D., New natural products in cancer chemotherapy. J. clin. Pharmacol., 30, 770-788 (1990).
18. STARK, G.R., DEBATISSE, M., GIULOTTO, E. and WAHL, G.M., Recent progress in understanding mechanisms of mammalian DNA amplification. Cell, 57, 901-908 (1989).
19. TEBBI, C.K., CHERVINSKY, D. and BAKER, R.M., Modulation of drug resistance in homoharringtonine-resistant C-1300 neuroblastoma cells with cyclosporine A and dipyridamole. J. cell. Physiol., 148, 464-471 (1991).
20. YE, J.-S., WANG, X-H., FENG, G.-H., LIANG, G.-R. and LIU, Z.-P., Small-dose harringtonine induces complete remission in patients with acute promyelocytic leukemia. Leukemia, 2, 427-429 (1988).
21. ZHOU, D.-C., MARIE, J.-P., MAISONNEUVE, L., SUBERVILLE, A.-M. and ZITTOUN, R., Effect of differentiating agents on modulation of MDR1-gene expression in multidrug-resistant hematopoietic HL60/DNR cell line. Exp. Hematol., 21, 779-784 (1993).
22. ZHOU, J.Y., CHEN, D.L., SHEN, Z.S. and KOEFFLER, H.P., Effect of homoharringtonine on proliferation and differentiation of human leukemic cells in vitro. Cancer Res., 50, 2031-2035 (1990).